annb0t
Top 20
AFT Pharmaceuticals (NZSE:AFT) has had a rough three months with its share price down 12%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. In this article, we decided to focus on AFT Pharmaceuticals' ROE.
Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing...
>>> Read more: Declining Stock and Solid Fundamentals: Is The Market Wrong About AFT Pharmaceuticals Limited (NZSE:AFT)?
Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing...
>>> Read more: Declining Stock and Solid Fundamentals: Is The Market Wrong About AFT Pharmaceuticals Limited (NZSE:AFT)?
